FrancophonIA/ELRC3.0 huggingface dataset:
English: MN results, similar to SRH results, demonstrated strong immune response after completion of priming vaccination series in a population of elderly subjects.
Croatian: Rezultati MN analize, slični rezultatima SRH analize, pokazali su snažan imunološki odgovor nakon dovršetka primarnog cijepljenja u populaciji starijih ispitanika.
English: The potential benefits to the mother and risks to the infant should be considered before administering AFLUNOV during breast-feeding.
Croatian: Potrebno je razmotriti moguće koristi za majku i rizike za dojenče prije primjene cjepiva AFLUNOV tijekom dojenja.
English: Adults from 18 onwards:
Croatian: Odrasli u dobi od 18 godina nadalje:
English: AFLUNOV is intended also to be given when there is anticipation of a possible pandemic due to the same or a similar strain.
Croatian: Cjepivo AFLUNOV je također namijenjeno za primjenu kada se predviđa mogućnost pandemije izazvane istim ili sličnim sojem virusa.
English: AFLUNOV may not fully protect everyone who is vaccinated, especially elderly subjects and those with weakened immune systems, such as HIV patients, or those with underlying long term medical problems, such as diabetes, lung disease or heart problems.
Croatian: Cjepivo AFLUNOV ne mora u potpunosti zaštititi svaku cijepljenu osobu, naročito ako se radi o starijim osobama i onim s oslabljenim imunološkim sustavom, kao što su bolesnici s HIV-om, ili oni kod kojih postoje dugotrajni zdravstveni problemi poput dijabetesa, plućnih ili srčanih bolesti.
English: There is limited experience in children between 6 months and 17 years of age.
Croatian: Postoji ograničeno iskustvo u djece u dobi od 6 mjeseci do 17 godina.
English: N=145 N=149 N=59 N=58 N=147 N=148 N=58 N=62
Croatian: Broj ispitanika N=145 N=149 N=59 N=58
English: Subjects with underlying medical or immunosuppressive conditions:
Croatian: Ispitanici s postojećim medicinskim stanjima ili stanjima imunosupresije:
English: Regardless of age, reactogencity was higher after the first dose than after the second vaccination.
Croatian: Bez obzira na dob reaktogenost je bila viša nakon prve doze nego nakon drugog cijepljenja.
English: * Seroprotection: SRH area ≥ 25 mm2
Croatian: * Seroprotekcija: SRH površina ≥25 mm2
English: However, in a pandemic situation caused by the strain included in this vaccine, it may be appropriate to give this vaccine to individuals with a history of anaphylaxis as defined above, provided that facilities for resuscitation are immediately available in case of need.
Croatian: Međutim, u pandemijskoj situaciji prouzročenoj sojem koji je uključen u ovo cjepivo, možda će biti potrebno dati cjepivo pojedincima s anafilaksijom u anamnezi kao što je gore definirano, pod uvjetom da su prostorije za oživljavanje odmah dostupne u slučaju potrebe.
English: EU/1/10/658/001 1 prefilled syringe EU/1/10/658/002 10 prefilled syringes
Croatian: EU/1/10/658/001 1 napunjena štrcaljka EU/1/10/658/002 10 napunjenih štrcaljki
English: 0.5 ml in pre-filled syringe (type I glass) with plunger-stopper (bromo-butyl rubber).
Croatian: 0,5 ml u napunjenoj štrcaljki (staklo tipa I) s čepom klipa (bromobutilna guma).
English: One dose of 0.5 ml contains: Influenza virus surface antigens (haemagglutinin and neuraminidase), propagated in fertilised hens' eggs from healthy chicken flocks, of strain:
Croatian: Jedna doza od 0,5 ml sadrži: površinski antigeni virusa influence (hemaglutinin i neuraminidaza), umnožen u oplođenim kokošjim jajima iz jata zdravih kokoši, soja:
English: It should be noted that the adverse reactions may be intensified.
Croatian: Važno je napomenuti da se nuspojave mogu pojačati.
English: • Erythema multiforme (type of allergic skin reaction that occurs in response to medications,
Croatian: • Multiformni eritem (vrsta alergijske kožne reakcije koja se pojavljuje kao odgovor na lijekove, infekcije ili bolest)
English: Do not use AFLUNOV after the expiry date which is stated on the carton and the label.
Croatian: AFLUNOV se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i naljepnici.
English: It is important that procedures are in place to avoid injury from faints
Croatian: Važno je osigurati odgovarajuće mjere zaštite kako bi se izbjegle ozljede prilikom nesvjestice.
English: Animals received one or two doses of vaccine containing 3.75 or 7.5 micrograms of antigen, followed by challenge with a lethal dose of A/Vietnam/1203/04 virus.
Croatian: Životinje su primile jednu ili dvije doze cjepiva koje je sadržavalo 3,75 ili 7,5 mikrograma antigena nakon čega je slijedila postvakcinacijska provokacija (engl. challenge) letalnom dozom virusa A/Vietnam/1203/04.
English: • Angioedema (abnormal swelling of the skin, usually around the eyes, lips, tongue, hands or feet, due to an allergic reaction).
Croatian: • Angioedem (nenormalno oticanje kože, obično oko očiju, usana, jezika, šaka i stopala zbog alergijske reakcije) • Problemi s probavom poput:
English: Post-marketing spontaneously reported adverse events and an interventional study do not suggest direct or indirect harmful effects of Focetria exposure on pregnancy.
Croatian: Spontane prijeve štetnih događaja tijekom praćenja nakon stavljanja cjepiva u promet kao i intervencijsko ispitivanje ne ukazuju da izloženost cjepivu Focetria ima izravne ili neizravne štetne učinke na trudnoću.
English: In both studies, subjects with underlying medical and immunosuppressive conditions reported higher frequencies of diarrhoea, loss of appetite and vomiting compared to healthy subjects (irrespective of age).
Croatian: U oba ispitivanja, ispitanici s postojećim medicinskim stanjem i stanjem imunosupresije prijavili su veću učestalost pojave dijaree, gubitka apetita i povraćanja u usporedbi sa zdravim ispitanicima (neovisno o dobi).
English: In addition, vomiting was commonly reported.
Croatian: Također, često je zabilježeno povraćanje.
English: Local Systemic
Croatian: Bilo koja Lokalna Sistemska
English: • Vasculitis (inflammation of the blood vessels which can cause skin rashes, joint pain and kidney problems)
Croatian: • Vaskulitis (upala krvnih žila koja može prouzročiti kožni osip, bol u zglobovima i probleme s bubrezima)
English: • Headache, dizziness, drowsiness, fainting.
Croatian: • Glavobolja, omaglica, omamljenost, nesvjestica
English: 1 pre-filled syringe (0.5 ml) 10 pre-filled syringes (0.5 ml)
Croatian: 1 napunjena štrcaljka (0,5 ml) 10 napunjenih štrcaljki (0,5 ml)
English: These studies provided limited immunogenicity data in subjects with some underlying medical (in particular, renal impairment and peripheral cardiovascular disease) and immunosuppressive conditions (in particular, transplant recipients and patients under cancer treatment).
Croatian: Ova ispitivanja pružila su ograničene podatke o imunogenosti u ispitanika s nekim postojećim medicinskim stanjem (osobito oštećenjem funkcije bubrega i perifernom kardiovaskularnom bolešću), odnosno stanjem imunosupresije (osobito primaoci transplantiranih organa i bolesnici koji se liječe od raka).
English: SRH seroprotection rates ranged from 86% to 98%, seroconversion rated from 64% to 90%, and GMR ranged from 2.92 to 4.57.
Croatian: Stope SRH seroprotekcije kretale su se od 86% do 98%, stope serokonverzije od 64% do 90%, a GMR-a između 2,92 i 4,57.
English: Your doctor needs to assess the benefits and potential risks of giving you the vaccine.
Croatian: Vaš liječnik treba procijeniti koristi i moguće rizike primjene cjepiva.
English: In toddlers, erythema and tenderness were the most commonly reported solicited local reactions; irritability and unusual crying were the most commonly reported solicited systemic reactions.
Croatian: Eritem i pojačana osjetljivost bili su najčešće prijavljene izazvane lokalne reakcije u male djece, a razdražljivost i neuobičajena plačljivost bile su najčešće prijavljene izazvane sistemske reakcije.
English: (≥1/10,000 to
Croatian: (≥1/10 000 i
English: The vaccine should be allowed to reach room temperature before use.
Croatian: Prije primjene cjepivo treba postići sobnu temperaturu.
English: Undesirable effects in patients with underlying long term medical problems such as diabetes, lung disease or heart problems and weakened immune systems (immunocompromised) such as HIV patients
Croatian: Neželjeni učinci u bolesnika s postojećim dugotrajnim zdravstvenim problemima, poput dijabetesa, plućnih i srčanih bolesti, i bolesnika s oslabljenim imunosnim sustavom (imunološki kompromitirani bolesnici) kao što su bolesnici s HIV-om.
English: The other ingredients are: sodium chloride, potassium chloride, potassium dihydrogen phosphate, disodium phosphate dihydrate, magnesium chloride hexahydrate, calcium chloride dihydrate, sodium citrate, citric acid and water for injections.
Croatian: Drugi sastojci su: natrijev klorid, kalijev klorid, kalijev dihidrogenfosfat, natrijev hidrogenfosfat dihidrat, magnezijev klorid heksahidrat, kalcijev klorid dihidrat, natrijev citrat, citratna kiselina i voda za injekcije.
English: All animals receiving 2 doses of AFLUNOV were protected, and 94% of animals receiving a single dose of AFLUNOV were protected.
Croatian: Sve životinje koje su primile 2 doze cjepiva AFLUNOV bile su zaštićene, baš kao i 94% životinja koje su primile samo jednu dozu cjepiva AFLUNOV.
English: Allergic reactions, anaphylaxis including dyspnoea, bronchospasm, laryngeal oedema, in rare cases leading to shock.
Croatian: Alergijske reakcije, anafilaksija uključujući dispneju, bronhospazam i edem larinksa, koji u rijetkim slučajevima dovode do šoka
English: Across studies V87_25 and V87_26, the safety of AFLUNOV in healthy adult and elderly subjects was consistent with existing safety data from previous clinical trials.
Croatian: U ispitivanjima V87_25 i V87_26, sigurnost cjepiva AFLUNOV u zdravih odraslih i starijih ispitanika bila je konzistentna s podacima o sigurnosti primjene dobivenim u prethodnim kliničkim ispitivanjima.
English: Following influenza vaccination, false positive serology test results may be obtained by the ELISA method for antibody to human immunodeficiency virus-1 (HIV-1), hepatitis C virus and, especially, human T-lymphotropic virus type 1 (HTLV-1).
Croatian: Nakon cijepljenja protiv influence mogući su lažno pozitivni rezultati serološkog određivanja protutijela metodom ELISA na virus humane imunodeficijencije-1 (HIV-1), virus hepatitisa C
English: Skin and subcutaneous tissue disorders Generalised skin reactions including pruritus, urticaria or non-specific rash; angioedema.
Croatian: Poremećaji kože i potkožnog tkiva Generalizirane kožne reakcije, uključujući svrbež, urtikariju ili nespecifični osip; angioedem
English: The vaccine should under no circumstances be administered intravascularly or intradermally.
Croatian: Cjepivo se ni u kojim okolnostima ne smije primijeniti intravaskularno ili intradermalno.
English: SRH results after the first dose, that mimic prepandemic priming plus single heterologous booster dose, revealed seroprotection and seroconversion rates of 100% (74100) and an 18-fold increase in SRH area (GMR).
Croatian: SRH rezultati nakon prve doze koja je oponašala primarno cijepljenje prepandemijskim cjepivom plus jednokratnu heterolognu booster dozu, pokazalo je stopu seroprotekcije i serokonverzije od 100% (74-100) i 18-sterostruki porast SRH površine (GMR).
English: V87P11 Adults (18-60 years) N=186
Croatian: V87P11 Odrasle osobe (18-60 godina) N=186
English: Up to 50% (n=33) of the elderly subjects aged 62 to 88 years immunised with AFLUNOV in trial V87P1 were seroprotected at six months.
Croatian: Do 50% (N=33) starijih ispitanika u dobi od 62 do 88 godina imuniziranih cjepivom AFLUNOV u ispitivanju V87P1 imalo je serozaštitu šest mjeseci.
English: After shaking, the normal appearance of AFLUNOV is a milky-white suspension.
Croatian: Nakon protresanja normalni izgled cjepiva AFLUNOV je mliječnobijela suspenzija.
English: Children (3-<9 years)
Croatian: Djeca (3-<9 godina)
English: In addition, antibody responses in patients with endogenous or iatrogenic immunosuppression may be insufficient to provide protection.
Croatian: Nadalje, stvaranje anitijela u bolesnika s endogenom ili jatrogenom imunosupresijom može biti nedovoljno za omogućavanje zaštite.
English: However, it is estimated that during the 2009 H1N1 pandemic more than 90,000 women were vaccinated during pregnancy with Focetria (an H1N1 pandemic vaccine similar to AFLUNOV) which contains the same amount of adjuvant MF59C.1 as AFLUNOV.
Croatian: Procjenjuje se da je 2009, tijekom pandemije H1N1 više od 90 000 žena cijepljeno tijekom trudnoće cjepivom Focetria (pandemijskim H1N1v cjepivom sličnim cjepivu AFLUNOV) koje sadrži istu količinu adjuvansa MF59C.1 kao AFLUNOV.
English: Based on humoral immune responses to the vaccine strain A/turkey/Turkey/1/2005 after two doses of AFLUNOV, a protective immune response may not be elicited in all vaccinees.
Croatian: Na temelju humoralnog imunonosnog odgovora na A/turkey/Turkey/1/2005 soj iz cjepiva, nakon primitka dvije doze cjepiva AFLUNOV, zaštitni imunonosni odgovor ne mora se postići u svih cijepljenih.
English: Side effects from clinical study in children (6 months to 17 years of age) General side effects reported very commonly in the 6 months to 35 months of age group were injection site redness, muscle ache, irritability and unusual crying.
Croatian: Nuspojave iz kliničkih ispitivanja u djece i adolescenata (u dobi od 6 mjeseci do 17 godina) Općenite nuspojave prijavljene vrlo često u dobnoj skupini od 6 do 35 mjeseci bile su crvenilo na mjestu injekcije, bol u mišićima, razdražljivost i neuobičajena plačljivost.
English: There are no data concerning human fertility.
Croatian: Plodnost Nema podataka koji se odnose na plodnost u ljudi.
English: The suspension is a milky-white liquid.
Croatian: Suspenzija je mliječnobijela tekućina.
English: Package leaflet: information for the user AFLUNOV suspension for injection in pre-filled syringe
Croatian: Uputa o lijeku: Informacije za korisnika AFLUNOV suspenzija za injekciju u napunjenoj štrcaljki
English: Currently available data in subjects aged 6 months to 18 years of age are described in section 5.1 but no recommendation on a posology can be made.
Croatian: Trenutno dostupni podaci u ispitanika u dobi od 6 mjeseci do 18 godina opisani su u dijelu 5.1
English: Protection against influenza There is no immune correlate of protection established for influenza A (H5N1).
Croatian: Nije utvrđen imunološki korelat zaštite za influencu A (H5N1).
English: Adults (18-60 years)
Croatian: Odrasli (18-60 godina)
English: 87% of animals challenged with virus heterologous to the vaccine strain after 2 doses of vaccine were protected, and a single dose of heterologous vaccine protected 56% of the animals.
Croatian: 87% životinja izloženih postvakcinacijskoj provokaciji virusom koji je heterologan soju cjepiva bilo je zaštićeno nakon 2 doze cjepiva, dok je samo jedna doza heterolognog cjepiva zaštitila 56% životinja.
English: Compared to the antibody levels obtained at day 43 after completion of primary vaccination schedules, antibody levels at day 202 were reduced by 1/5 to 1/2 from their prior levels.
Croatian: U usporedbi s razinama protutijela dobivenim 43. dan nakon dovršetka rasporeda prvog cijepljenja, razine protutijela 202. dana smanjile su se za 1/5 do 1/2 u odnosu na prethodne vrijednosti.
English: AFLUNOV is a vaccine for use in adults from 18 onwards, intended to be given in the context of outbreaks of zoonotic influenza viruses (coming from birds) with pandemic potential to prevent flu caused by H5N1 viruses similar to the vaccine strain reported in section 6.
Croatian: AFLUNOV je cjepivo za primjenu u odraslih osoba u dobi od 18 godina nadalje, namijenjeno za primjenu u kontekstu izbijanja gripe izazvane zoonoznim virusom (virusom koji dolazi od ptica) s pandemijskim potencijalom, a radi sprječavanja gripe uzrokovane H5N1 virusima sličnima soju u cjepivu kako je navedeno u dijelu 6.
English: Very common (≥1/10); Common (≥1/100 to <1/10); Uncommon (≥1/1,000 to <1/100); Rare
Croatian: Vrlo često (≥1/10), često (≥1/100 i <1/10), manje često (≥1/1000 i <1/100), rijetko (≥1/10 000 i
English: Ferrets received one or two doses of vaccine (A/Vietnam/1194/2004).
Croatian: Afrički tvorovi primili su jednu ili dvije doze cjepiva (A/Vietnam/1194/2004).
English: The vaccine contains per 0.5 ml 9.75 mg squalene, 1.175 mg polysorbate 80, 1.175 mg sorbitan trioleate.
Croatian: Cjepivo po dozi od 0,5 ml sadrži 9,75 mg skvalena, 1,175 mg polisorbata 80, 1,175 mg sorbitan trioleata.
English: Immunocompromised N=139
Croatian: Imunološki kompromitirani N=139
English: a actual age range of population enrolled
Croatian: a trenutni raspon godina populacije uključene u ispitivanje
English: • Severe stabbing or throbbing pain along one or more nerves
Croatian: • Neurološki poremećaji poput • Jake probadajuće ili pulsirajuće boli duž jednog ili više živaca
English: The adverse reaction rates reported after any vaccination doses (i.e. 1st, 2nd or booster) were similar and are listed according to the following MedDRA frequency convention and system organ class:
Croatian: Stope nuspojava prijavljenih nakon bilo koje doze primljenog cjepiva (tj. 1., 2. ili boostera) bile su slične i navedene su prema MedDRA definicijama učestalosti nuspojava i klasifikaciji organskih sustava:
English: In the event of an officially declared influenza pandemic due to A/H5N1 virus, persons previously vaccinated with one or two doses of AFLUNOV that contained haemagglutinin (HA) antigen derived from a different clade of the same influenza subtype as the influenza pandemic strain may receive a single dose of AFLUNOV instead of two doses that are required in previously unvaccinated individuals (see section 5.1).
Croatian: U slučaju službeno proglašene pandemije influence prouzročene virusom A/H5N1 osobe prethodno cijepljene s jednom ili dvije doze cjepiva AFLUNOV koje je sadržavalo antigen hemaglutinin (HA) dobiven iz različite klade (genetske podskupine) istog podtipa influence kao pandemijski soj influence mogu primiti samo jednu dozu cjepiva AFLUNOV umjesto dviju doza koje su potrebne u prethodno necijepljenih pojedinaca (vidjeti dio 5.1).
English: (≥1/10,000 to <1/1,000); Very rare (<1/10,000).
Croatian: <1/1000) i vrlo rijetko (<1/10 000).
English: Name and address of the manufacturers of the biological active substance Seqirus Vaccines Ltd
Croatian: Naziv i adresa proizvođača biološke djelatne tvari Seqirus Vaccines Ltd
English: Based on data obtained from trials V87P1, V87P11 and V87_13, persistence of antibodies after primary vaccination in elderly subjects as assessed by HI, SRH, and MN tests reduced from 1/2 to 1/5th of their post-vaccination level at day 202 as compared to day 43 after completion of primary schedules.
Croatian: Na temelju podataka prikupljenih u ispitivanjima V87P1, V87P11 i V87_13, postojanost protutijela nakon prvog cijepljenja u starijih ispitanika procijenjena na temelju HI, SRH i MN analiza smanjila se s 1/2 na 1/5 njihove postvakcinalne razine 202. dana u usporedbi s 43. danom nakon dovršetka rasporeda primarnog cijepljenja.
English: The incidence of AFLUNOV (A/Vietnam/1194/2004) adverse reactions has been evaluated in one clinical trial (V87P6) in children (6 months to 17 years old).
Croatian: Incidencija nuspojava cjepiva AFLUNOV (A/Vietnam/1194/2004) procijenjena je u jednom kliničkom ispitivanju (V87P6) u djece (u dobi od 6 mjeseci do 17 godina).
English: A third (booster) dose of AFLUNOV was administered 6 months onwards after the primary vaccination.
Croatian: Treća (booster) doza cjepiva AFLUNOV primijenjena je 6 mjeseci nadalje nakon prvog cijepljenja.
English: Injection 1
Croatian: Injekcija 1
English: AFLUNOV contains sodium and potassium.
Croatian: AFLUNOV sadrži natrij i kalij
English: Data obtained in adults showed that AFLUNOV can be given at the same time as non-adjuvanted seasonal influenza vaccines.
Croatian: Podaci dobiveni u odraslih osoba pokazali su da se AFLUNOV može primijeniti istodobno s neadjuvantiranim cjepivima protiv sezonske gripe.
English: *actual age range of population enrolled
Croatian: *trenutni raspon dobi populacije uključene u ispitivanje
English: If co-administration with another vaccine is considered, immunisation should be carried out on separate limbs.
Croatian: Ako se razmatra istodobna primjena s drugim cjepivom, imunizaciju treba provesti na suprotnim udovima.
English: Two doses of AFLUNOV were administered three weeks apart and a third dose 12 months following the first dose.
Croatian: Dvije doze cjepiva AFLUNOV primijenjene su u razmaku od tri tjedna, a treća doza 12 mjeseci nakon prve doze.
English: 1.175 milligrams per 0.5 ml sorbitan trioleate
Croatian: 1,175 miligrama na 0,5 ml sorbitan trioleat
English: 1.175 milligrams per 0.5 ml
Croatian: 1,175 miligrama na 0,5 ml
English: Data on safety of a booster dose of AFLUNOV are limited to three trials (V87P1, V87P2 and V87P1E1) that included 116 adults (18-60 years) and 56 elderly subjects (>61 years).
Croatian: Podaci o sigurnosti booster doze cjepiva AFLUNOV ograničeni su na tri ispitivanja (V87P1, V87P2 i V87P1E1) koja su uključivala 116 odraslih osoba (18-60 godina) i 56 starijih osoba (≥61 godine).
English: The following additional adverse events were reported from post-marketing surveillance with seasonal non-adjuvanted trivalent vaccines in all age groups and a seasonal trivalent MF59-adjuvanted subunit influenza vaccine approved for use in elderly subjects 65 years of age and older:
Croatian: Sljedeći dodatni štetni događaji prijavljeni su tijekom praćenja nakon stavljanja u promet sezonskih neadjuvantiranih trovalentnih cjepiva u svim dobnim skupinama i sezonskog trovalentnog MF59 adjuvantiranog podjediničnog cjepiva protiv influence, a koje je odobreno za primjenu u starijih osoba u dobi od 65 godina naviše:
English: The side effects listed below have occurred in the days or weeks after vaccination with another vaccine called Focetria H1N1v similar to AFLUNOV.
Croatian: Niže navedene nuspojave pojavile su se u danima ili tjednima nakon cijepljenja drugim cjepivom naziva Focetria H1N1v, a koje je slično cjepivu AFLUNOV.
English: administered 12 months following the first dose, was higher than after both first and second doses.
Croatian: Reaktogenost nakon treće doze, primijenjene 12 mjeseci nakon prve doze, bila je viša nego nakon prve i druge doze.
English: How AFLUNOV is given
Croatian: Kako se AFLUNOV daje
English: • extensive swelling of injected limb lasting more than one week.
Croatian: • Prekomjerno oteknuće ekstremiteta u koji je ubrizgano cjepivo, a koje traje duže od jednog tjedna
English: Warning: Do not inject intravascularly or intradermally.
Croatian: Upozorenje: ne injicirati u žilu ili u kožu.
English: In this study 100% of animals were protected against homologous challenge, and 81% of animals were protected against heterologous challenge.
Croatian: U tom je ispitivanju 100% životinja bilo zaštićeno od postvakcinacijske provokacije homolognim virusom, a 81% životinja bilo je zaštićeno od postvakcinacijske provokacije heterolognim virusom.
English: 9.75 milligrams per 0.5 ml polysorbate 80
Croatian: 9,75 miligrama na 0,5 ml polisorbat 80
English: There are no data regarding the use of AFLUNOV during breast-feeding.
Croatian: Nema podataka o uporabi cjepiva AFLUNOV tijekom dojenja.
English: Nervous system disorders Neurological disorders, such as encephalomyelitis, and Guillain Barré syndrome.
Croatian: Poremećaji živčanog sustava Neurološki poremećaji kao što su encefalomijelitis i Guillain Barréov sindrom
English: In these trials, lower levels of antibodies and reduced seroprotection rates against homologous H5N1 A/turkey/Turkey/1/2005 were also measured in healthy elderly subjects, as compared to healthy adults, though previous studies showed induction of sufficiently immunogenic responses against H5N1 strains (see above for information on elderly).
Croatian: U tim ispitivanjima su u zdravih starijih ispitanika također izmjerene niže razine protutijela i smanjene stope seroprotekcije protiv homolognog virusa podtipa H5N1 A/turkey/Turkey/1/2005 u usporedbi sa zdravim odraslima, iako su prethodna ispitivanja pokazala induciranje dovoljnog imunosnog odgovora protiv sojeva H5N1 (vidjeti gore za podatke za starije osobe).